Literature DB >> 3324444

Expression of proto-oncogenes in xenografts of human renal cell carcinomas.

H F Karthaus1, M J Bussemakers, J A Schalken, K H Kurth, W F Feitz, F M Debruyne, H P Bloemers, W J Van de Ven.   

Abstract

In a recent paper, we described the expression pattern of proto-oncogenes in primary human renal cell carcinoma [12]. To test the possibility of using xenografts as a useful alternative for such studies, we analyzed xenografts of a number of human renal cell carcinomas in nu/nu mice. Xenografts included RC2, RC14, RC21, RC43 and NC65. Northern blot analysis indicated that c-Ras was expressed in all these xenografts. The identity of the ras transcripts in the individual xenografts was further specified as c-Ha-ras, c-Ki-ras or N-ras. Expression of c-myc and the p53 gene was also found in a number of these tumors. Only RC21 failed to express the c-myc or the p53 gene. In all xenografts, a 3.0 kb c-fes/fps mRNA was present. In RC2, RC14, RC21 and RC43, low levels of the 4.8 kb ab 1 transcript were detectable. Transcripts of myb and sis could not be detected in any of the xenografts. The results indicated that the expression pattern of a variety of proto-oncogenes in xenografts of human renal cell carcinomas was similar to that in the primary tumors.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3324444     DOI: 10.1007/bf00265665

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  23 in total

Review 1.  Viral oncogenes.

Authors:  J M Bishop
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

2.  The action of oncogenes in the cytoplasm and nucleus.

Authors:  R A Weinberg
Journal:  Science       Date:  1985-11-15       Impact factor: 47.728

3.  Absence of thymus in a mouse mutant.

Authors:  E M Pantelouris
Journal:  Nature       Date:  1968-01-27       Impact factor: 49.962

4.  Genomic sequencing.

Authors:  G M Church; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

5.  Reconstitution of p53 expression in a nonproducer Ab-MuLV-transformed cell line by transfection of a functional p53 gene.

Authors:  D Wolf; N Harris; V Rotter
Journal:  Cell       Date:  1984-08       Impact factor: 41.582

6.  Expression of cellular homologues of retroviral onc genes in human hematopoietic cells.

Authors:  E H Westin; F Wong-Staal; E P Gelmann; R Dalla-Favera; T S Papas; J A Lautenberger; A Eva; E P Reddy; S R Tronick; S A Aaronson; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

7.  Amplification of the c-myb oncogene in a case of human acute myelogenous leukemia.

Authors:  P G Pelicci; L Lanfrancone; M D Brathwaite; S R Wolman; R Dalla-Favera
Journal:  Science       Date:  1984-06-08       Impact factor: 47.728

8.  Heterotransplantation of human cancers into nude mice: a model system for human cancer chemotherapy.

Authors:  B C Giovanella; J S Stehlin; L J Williams; S S Lee; R C Shepard
Journal:  Cancer       Date:  1978-11       Impact factor: 6.860

9.  L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer.

Authors:  M M Nau; B J Brooks; J Battey; E Sausville; A F Gazdar; I R Kirsch; O W McBride; V Bertness; G F Hollis; J D Minna
Journal:  Nature       Date:  1985 Nov 7-13       Impact factor: 49.962

10.  Evolutionary conserved close linkage of the c-fes/fps proto-oncogene and genetic sequences encoding a receptor-like protein.

Authors:  A J Roebroek; J A Schalken; J A Leunissen; C Onnekink; H P Bloemers; W J Van de Ven
Journal:  EMBO J       Date:  1986-09       Impact factor: 11.598

View more
  2 in total

1.  Cytomorphological, cytogenetic, and molecular biological characterization of four new human renal carcinoma cell lines of the clear cell type.

Authors:  C D Gerharz; U Ramp; J Olert; R Moll; S Störkel; N Marx; H E Gabbert
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

2.  Transformation of human kidney proximal tubule cells by ras-containing retroviruses. Implications for tumor progression.

Authors:  D M Nanus; S A Ebrahim; N H Bander; F X Real; L M Pfeffer; J R Shapiro; A P Albino
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.